Back to 
AMERIPRISE FINANCIAL INC
AMERIPRISE FINANCIAL INC
MRTXShowing 0 of 20 quarters
Position history for AMERIPRISE FINANCIAL INC's holdings in MIRATI THERAPEUTICS INC
As of its Q4 2023 13F, Ameriprise Financial held 7,371 shares of MRTX (Mirati Therapeutics), worth $433,047. Ameriprise Financial's 13F filings listed MRTX from Q3 2023 to Q4 2023, 2 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of MRTX: Avoro Capital Advisors LLC